Successful US FDA Audit

The auditor's report went out positive with no FDA-483 and not a single observation, which stands as an excellent performance for a young company.

The basis of the initial audit was to determine whether policies and practices met the high standards requiered by the US government for the import of Medical Devices into th […]

Back home
Creaspine's news
Company profile
Beliefs and focus
Products US
Products international
Creaspine | Plateforme Technologique d’Innovation Biomédicale | Hôpital Xavier Arnozan | Av. du Haut-Lévêque 33600 Pessac - France - Phone : +33 (0)5 57 10 28 54